healthcare stocks

Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Sunday, December 21, 2025 — With U.S. markets heading into a holiday-shortened final trading stretch, healthcare stocks are back in focus as investors weigh a year-end “Santa rally” against a fast-moving policy backdrop that is unusually direct for the sector:

21 December 2025

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements,

20 December 2025

Biotech · Drug Pricing · Healthcare · Market Outlook · NASDAQ:AMGN · NASDAQ:GILD · NYSE:BMY · NYSE:GSK · NYSE:MRK · NYSE:NVS · NYSE:SNY · Stock Market

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Updated: December 14, 2025Coverage window for this report: December 8–14, 2025 Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the

14 December 2025

Earnings · Healthcare · Industry News · Pharmaceuticals · US Stocks

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the

13 December 2025

Financial News · Healthcare Stocks · Investment Analysis · Market Forecasts · NYSE:HCA · Stock Market

Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health Inc. (NYSE: OSCR) has just delivered one of the wildest weeks in its short public-market life: the stock jumped roughly 35% on hopes that the White House will extend Affordable Care Act (ACA) subsidies, then ran straight into

7 December 2025

Financial News · Health Insurance · Investment Analysis · Market Trends · NYSE:OSCR · Stock Market

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group Incorporated (NYSE: UNH) is back under intense scrutiny from Wall Street and regulators after one of the most turbulent stretches in its history. As of Thursday, December 4, 2025, UNH stock is trading around $333–340 per share, giving

4 December 2025

Analyst Forecasts · Company Analysis · Financial News · Investment · NYSE:UNH · Stock Market

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group’s UNH stock has become one of the most controversial names in the Dow in 2025. After a brutal sell-off driven by a massive cyberattack, rising medical costs and intensifying federal investigations, the stock is trying to stage a

15 November 2025

Financial Forecasts · Healthcare Industry · Investment Analysis · NYSE:UNH · Stock Market · UnitedHealth Group

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)

Key Facts: Oscar Health’s stock recently jumped to roughly $21.5 on Oct 3, 2025 (up ≈11% that day) indmoney.com. Over the past week, the stock is up about 8% marketscreener.com. In Q2 2025, Oscar reported $2.9 billion revenue (+28–30% YoY) but

3 October 2025

Analyst Insights · Financial News · Healthcare Stocks · Investments · NYSE:OSCR · Stock Market

Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Stock Performance (Oct 3, 2025) As of midday Oct 3, Humana shares were $272.05, up about +6.01% on the day reuters.com. Yesterday’s close (Oct 2) was $256.62 reuters.com, so HUM has recovered much of last week’s slide. In fact, Oct 1 saw a ~5% drop

3 October 2025

Financial News · Healthcare · Investing · Medicare · NYSE:HUM · Stock Market · Stocks